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A B S T R A C T
The aim of this study was to evaluate the anti-inflammatory activity of Petit Verdot Extract
and hexane, chloroform and ethyl acetate fractions obtained from grape pomace, in addi-
tion to identifying active compounds. The PVE and EAF reduced significantly paw edema
and neutrophil migration when compared with control groups. The PVE reduced levels of
TNF-α and IL1-β in the peritoneal fluid, whereas the EAF did not reduce cytokines signifi-
cantly. Two hydroxybenzoic acids, two proanthocyanidins, three flavan-3-ol monomers and
three anthocyanins were identified in the PVE and EAF by LC-MS/MS. The stilbene trans-
resveratrol was identified only in the EAF. The phenolic compounds were quantified using
HPLC-DAD analysis, except for the stilbenes, which were not sensible for the detection by
the method. Since PVE and EAF showed significantly anti-inflammatory effects and high
concentration of phenolic compounds, we concluded that Petit Verdot pomace could be an
interesting source of anti-inflammatory bioactives.
© 2014 Elsevier Ltd. All rights reserved.
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1. Introduction
For hundreds of years, Vitis vinifera (grape) has been culti-
vated and used due to its important nutritional and medici-
nal properties (Yadav et al., 2009). Among its medicinal
properties what stands out are mainly its antioxidant,
cardioprotective, anticancer, antibacterial, antidiabetic and anti-
inflammatory actions (Bralley, Hargrove, Greenspan, & Hartle,
2007; Nassiri-Asl & Hosseinzadeh, 2009; Yadav et al., 2009).
The phytochemical constituents of grape are mostly phe-
nolic compounds such as flavonoids (anthocyanins, flavonols
and flavanols), stilbenes (resveratrol), phenolic acids (benzoic,
cinnamic acids and its derivatives) and a wide variety of tannins
(Nassiri-Asl & Hosseinzadeh, 2009). Several findings have es-
tablished that resveratrol, the major compound extracted from
the skin and seeds of some varieties of grape, has potent anti-
inflammatory and immunomodulatory activities (Xia, Deng,
Guo, & Li, 2010; Yadav et al., 2009). Many others bioactives
from grape also exhibit those properties; among the most
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important are polyphenolic compounds. However, its mecha-
nism of action, though still not clear, has been linked to in-
hibition of inflammatory cytokines (Byun, Choi, Sung, & Byun,
2012; Chuang & McIntosh, 2011; Yadav et al., 2009).
Grape varieties are cultivated in distinct areas around the
world producing large quantities of by-products. About 80% of
the total crop is used in wine making and pomace represents
approximately 20% of the weight of grapes processed (Schieber,
Stintzing, & Carle, 2001). Recent data show a global grape pro-
duction around 691 million tons (Karlsson, 2013) that can
provide nearly 110 million tons of pomace. Many authors have
shown that after wine production considerable phenolic com-
pounds are still present in significant amounts in by-products
(Melo et al., 2011; Schieber et al., 2001). Therefore, such mate-
rial could be an interesting source of active compounds with
different biological activities (Melo et al., 2011; Moure et al., 2001)
and could be incorporated into pharmaceutical, nutraceutical
or cosmetic formulations (Alonso, Guilleän, Barroso, Puertas,
& Garciäa, 2002; Chen & Kang, 2013; Schieber et al., 2001).
Currently, the French grape variety Petit Verdot is being
grown in the Valley of the São Francisco River, Pernambuco,
Brazil, to produce aged fine wines due to the high phenolic po-
tential. Acclimatized for the first time in a tropical area, this
variety has become the target of several research for its chemi-
cal composition as well as its biological properties (Pereira,
Araújo, Santos, Vanderlinde, & Lima, 2011). A preliminary study
in mice paw edema model selected the ethanolic extract from
Petit Verdot pomace, due to anti-inflammatory effects and high
level of phenolic content. Thus, the aim of this study was to
evaluate the anti-inflammatory activity of Petit Verdot Extract
(PVE) and its fractions hexane (HF), chloroform (CF) and ethyl
acetate (EAF) obtained from grape pomace, in addition to iden-
tifying potential active fractions or compounds.
2. Material and methods
2.1. Plant material
The pomace, from the processing grape Petit Verdot was pro-
vided by ‘EMBRAPA Semi-Árido’, located in the City of Petrolina,
Pernambuco, Brazil, in September 2011.The material (1024.41 g)
was lyophilized, homogenized, weighed and stored at −18 °C.
2.2. Preparation of extract and fractions
The air-dried and powdered grape pomace (200 g) was ex-
tracted with 320 mL of ethanol (EtOH) and 80 mL of water (H2O)
by using an ultrasound for 30 min (three times). The ob-
tained PVE was filtered and evaporated by using a rotary evapo-
rator and freeze dryer to give the crude dried extract.The dried
extract was stored at −18 °C until used. The PVE was further
fractioned using a liquid–liquid extraction technique with
hexane, chloroform, and ethyl acetate solvents. The fractions
obtained were monitored by thin layer chromatography (TLC)
using the anisaldehyde reagent (4-methoxy-benzaldehyde,
acetic acid, sulfuric acid, 1.0:48.5:0.5) and followed by incuba-
tion at 100 °C for 5 min. Fluorescent substances were visual-
ized under UV light at the wavelengths of 254 and 366 nm.The
PVE and its hexanic, chloroform and ethyl acetate fractions were
concentrated in a rotaevaporator at 40 °C.The extract and frac-
tions were dissolved in PBS at 1 mM (vehicle) for oral (v.o.) sub-
cutaneous (s.c.) or intraperitoneal (i.p.) administration.
2.3. Animals
Male Balb/c albino mice (20–25 g), SPF (specific-pathogen free),
were purchased from CEMIB/UNICAMP (Multidisciplinary Center
for Biological Research, SP, Brazil) and used as experimental
animals. The mice were maintained in a room with con-
trolled temperature (22 ± 2 °C) for 12 h light/12 h dark cycle, hu-
midity (40–60%), with food (standard pellet diet) and water
provided ad libitum. The experiments were conducted in ac-
cordance with the Guide for the Care and Use of Laboratory
Animals and had prior approval from the local Animal Ethics
Committee (CEUA UNICAMP process number 2155-1).
2.4. Anti-inflammatory activity
2.4.1. Carrageenan-induced paw edema
The method of Winter et al., 1962 was followed. Paw edema
was induced by subplantar injection of 0.05 mL of lambda car-
rageenan (1% w/v in 0.9% of saline) into the plantar of the left
hind paw in mice.An equal volume of vehicle was injected into
the contralateral paw.The volume of both hind-paws up to the
ankle joint was measured with a plethysmometer (model 7140,
Ugo Basile) immediately before (0), 1, 2, 3, 4 and 5 h after car-
rageenan. The difference in the volumes between the hind-
paws was a measure of the edema (mL). The PVE (30, 100, 300
and 1000 mg kg−1), hexanic (HF), chloroform (CF) and ethyl
acetate (EAF) fractions (100 mg kg−1), the reference drug, indo-
methacin (10 mg kg−1), or the vehicle (10 mL kg−1), were given
orally (v.o.) or intraperitoneally (i.p.) 1 h or 0.5 h respectively,
before the carrageenan subplantar injection.
2.4.2. Neutrophils migration in the peritoneal cavity
For the determination of neutrophil migration to peritoneal
cavity, PVE (30, 100 and 300mg kg−1), EAF (25, 50 and 100mg kg−1),
indomethacin (10 mg kg−1) or vehicle were administered by sub-
cutaneous (s.c.) injection, 30 min before the administration of
inflammatory stimuli by intraperitoneal injection of carra-
geenan at 500 μg/cavity. Mice were killed 4 h after the chal-
lenge (carrageenan) administration and the peritoneal cavity
cells were harvested by washing the cavity with 3 mL of phos-
phate buffered saline (PBS) containing EDTA 1mM.The volumes
recovered were similar in all experimental groups and equated
to approximately 95% of the injected volume. In order to count
the total number of cells, a Newbauer chamber was used.
Smears were prepared using a cytocentrifuge (Cytospin 3;
Shandon Lipshaw), stained with Panotic® staining kit and the
different cells were counted (until 100 cells) using an optical
microscope (1000×). The results are presented as the number
of neutrophils per cavity.
2.4.3. Cytokine assays
The mice were treated with PVE (300 mg kg−1, s.c.) or EAF
(100 mg kg−1, s.c.) 30 min before the administration of inflam-
matory stimuli by intraperitoneal injection of carrageenan at
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500 μg/cavity. Vehicle was used as the negative control. After
3 h, animals were killed and the peritoneal cavity cells were
harvested by washing the cavity with 3 mL of phosphate buff-
ered saline (PBS) containing EDTA 1 mM. The volumes recov-
ered were similar in all experimental groups and equated to
approximately 95% of the injected volume. Levels of TNF-α and
IL-1β were determined by ELISA using protocols supplied by
the manufacturers (R&D Systems®) from both experiments.
The results are expressed as picograms.
2.5. Chemical analysis
2.5.1. Total phenolic content
The analysis of total phenolic compounds was performed ac-
cording to the spectrophotometric method of Folin–Ciocalteu,
described by Al-Duais et al. (2009), with some modifications.
Aliquots of 20 μL of the standard solution or the sample and
100 μL of the Folin–Ciocalteu solution at the concentration of
10% in water were pipetted into each microplate well and, after
5 min, 75 μL of the aqueous solution of sodium carbonate 7.5%
was added.The control was prepared by substituting the sample
by distilled water. Readings were performed at 740 nm after
40 min of the reaction, in a microplate reader (Molecular
Devices).The calibration curve was constructed using gallic acid
with concentrations from 20 to 120 μg mL−1.
2.5.2. LC-MS/MS analysis
Liquid chromatography (LC) analyses were performed on a
Shimadzu (Kyoto, Japan) HPLC system consisting of an LC 10AD
solvent pump, an SLC 10A system controller, a CTO 10AS
column oven, and a 7125 Rheodyne injector (Rheodyne, Cotati,
CA, USA), with a 20 μL loop. Separation was obtained on a
S5–100 ODS column (250 mm × 4.6 mm ID, 5 μm particle
size, Rexchrom, Morton Grove, USA). A guard column
(10 mm × 4.6 mm ID, 5 μm particle size, Rexchrom, Morton
Grove, USA) was employed. The mobile phase for the analy-
sis consisted in a mixture of methanol:water (40:60, v/v) with
1% formic acid, at a flow rate of 0.8 mL min−1 delivered by
isocratic elution.The LC eluent was split by aValco zero-dead-
volume internal Tee (Restek, Pennsylvania, USA), and a flow
rate of approximately 0.2 mL min−1 was introduced into the
stainless steel capillary probe of the MS system.
The tandem mass spectrometry (MS/MS) system em-
ployed for analyte identities conformation analyses was a
Quattro LC triple quadrupole (Micromass,Manchester, UK) fitted
with a Z-electrospray (ESI) interface operating with positive and
negative ion modes. The temperatures of source block and
dessolvation gas were set at 100 °C and 350 °C, respectively. Ni-
trogen was used as both drying and nebulizing gas, while argon
was used as collision gas. The cone voltage employed during
the analyses was 20 V and the collision energy ranged from
20 to 30 eV among the analyte analyses. The analyses were
carried out in the multiple-reaction monitoring (MRM) mode
for identities confirmation. ESI positive mode was employed
and protonated ions [M + H]+ and their respective product ions
were monitored for analyses of anthocyanins. Hidroxybenzoic
acids, proantocyanidins, flavan-3-ol-monomers and stilbene
analyses were carried out using ESI negative mode and
deprotonated ions [M–H]− and their respective product ions were
monitored. Concentrated samples were diluted around 8% in
the LC mobile phase, and 20 μL were injected in the system
LC-MS/MS.The following authentic standards of hidroxybenzoic
acids, proantocyanidins, flavan-3-ol-monomers, stilbenes and
anthocyanins (Sigma-Aldrich®) were examined: gallic acid,
syringic acid, procyanidin B1, procyanidin B2, catequin,
epicatechin, epicatechin-3-O-gallate, trans-resveratrol, trans-
piceid, peonidin-3-O-glucoside, malvidin-3-O-glucoside and
delphinidin-3-O-glucoside.
2.5.3. Quantitative analysis by HPLC-DAD
HPLC analyses were carried out using an analytical HPLC unit,
equipped with Shimadzu ODS-A column (4.6 mm × 250 mm,
5 μm) and photodiode array detector (SPD-M10AVp, Shimadzu
Co.). Twenty microliters of PVE and active fraction (EAF) was
injected into a liquid chromatography system.The column flow
rate was 1.0 mL min−1. For analysis of all phenolic com-
pounds except anthocyanins, the mobile phase consisted of
water/formic acid (99.9/0.1, v/v) (A) and acetonitrile/formic acid
(99.9/0.1, v/v) (B), starting by 5% B and increasing to 7% B (7 min),
20% B (50 min), 45% B (70 min), 100% B (85 min), held at 100%
B for 10 min, and decreasing to 5% B (105 min). For analysis
of anthocyanins, the mobile phase consisted of water/formic
acid (90/10, v/v) (A) and methanol (B), starting with 5% B and
increasing to 60% B (20 min), 100% B (25 min), held at 100% B
for 5 min, and decreasing to 5% B (38 min). The column
was maintained at a constant temperature of 30 °C. The
chromatograms were analyzed using Class-VP® software. The
following authentic standards of hidroxybenzoic acids,
proantocyanidins, flavan-3-ol-monomers, stilbenes and an-
thocyanins (Sigma-Aldrich®) were examined: gallic acid, syringic
acid, procyanidin B1, procyanidin B2, catechin, epicatechin,
epicatechin-3-O-gallate, trans-resveratrol, trans-piceid, peonidin-
3-O-glucoside, malvidin-3-O-glucoside and delphinidin-3-O-
glucoside. Limits of detection and quantification (LOD and LOQ)
were calculated using the following equations:
LOD s S= ×3 3.
LOQ s S= ×10
where ‘s’ is the estimated standard deviation of the linear co-
efficient of the equation, and ‘S’ is the slope of the analytical
curve.
2.6. Statistical analysis
Data were expressed as mean ± standard error of the mean
(SEM) and statistical comparison between groups was made
utilizing analysis of variance (ANOVA) followed by Tukey or
Dunnett test. Significance was accepted when p ≤ 0.05.
3. Results
The oral administration of PVE at 1000 mg kg−1 on paw edema
assay showed maximal inhibition after 3 h (0.02 ± 0.00), p < 0.01
when compared with the negative control (0.08 ± 0.01).The posi-
tive control group, indomethacin showed maximal inhibition
also at 3 h (0.02 ± 0.00), p < 0.05 (Table 1).
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The intraperitoneal administration of PVE at 30 mg kg−1 on
paw edema assay, showed maximal inhibition after 3 h
(0.06 ± 0.03), p < 0.05 when compared with the negative control
(0.15 ± 0.03), p < 0.05, at a dose of 100 mg kg−1showed maximal
inhibition after 2 h (0.06 ± 0.04), p < 0.05 when compared with
the negative control (0.13 ± 0.03), p < 0.05. The higher dose
(300 mg kg−1) showed maximal inhibition after 5 h (0.04 ± 0.01),
p < 0.05 when compared with the negative control (0.18 ± 0.03),
p < 0.05. The positive control group, indomethacin showed
maximal inhibition at 3 h (0.13 ± 0.02), p < 0.05 (Table 2).
After the fractionation process, the PVE has generated three
fractions (HF, CF and EAF). The extract as well as the frac-
tions were tested by paw edema assay in another experi-
ment. From the results, we selected the EAF as the active
fraction (Table 3). Then, the effect of three different doses of
EAF is shown in Table 4 and demonstrated that the active frac-
tion inhibited paw edema with a lower dose than the extract.
The administration (s.c.) of PVE extract at doses of 30 and
100 mg kg−1 did not reduce neutrophil migration induced by car-
rageenan. The dose of 300 mg kg−1 decreased neutrophil mi-
Table 1 – Effect of oral administration of Petit Verdot Extract (PVE) on carrageenan-induced paw edema in mice.
Group Dose (mg kg–1) Mean edema ΔV mL (percent inhibition)
1 h 2 h 3 h 4 h 5 h
Control – 0.05 ± 0.01 0.07 ± 0.01 0.08 ± 0.01 0.10 ± 0.01 0.11 ± 0.01
Indomethacin 10 0.05 ± 0.00
–
0.03 ± 0.00*
(53)
0.02 ± 0.00**
(73)
0.03 ± 0.01**
(67)
0.04 ± 0.01*
(61)
PVE 1000 0.06 ± 0.01
–
0.03 ± 0.01*
(46)
0.02 ± 0.00**
(67)
0.05 ± 0.00*
(44)
0.10 ± 0.00
(14)
The values represent the means difference of volume of paw ± S.E.M.; n = 5.
*p < 0.05 and **p < 0.01, significantly different compared with control (ANOVA followed by Dunnett test).
Table 2 – Effect of intraperitoneal administration Petit Verdot Extract (PVE) on carrageenan-induced paw edema in mice.
Group Dose (mg kg–1) Mean edema ΔV mL (percent inhibition)
1 h 2 h 3 h 4 h 5 h
Control – 0.11 ± 0.01 0.13 ± 0.02 0.15 ± 0.03 0.17 ± 0.03 0.18 ± 0.03
Indomethacin 10 0.07 ± 0.02
(31)
0.10 ± 0.03*
(23)
0.13 ± 0.02*
(10)
0.13 ± 0.05*
(23)
0.13 ± 0.02
(24)
PVE 30 0.09 ± 0.03
(16)
0.06 ± 0.02***
(55)
0.07 ± 0.04**
(53)
0.07 ± 0.01***
(54)
0.10 ± 0.03**
(41)
PVE 100 0.11 ± 0.01
(1)
0.06 ± 0.04***
(53)
0.09 ± 0.07*
(40)
0.10 ± 0.05*
(39)
0.11 ± 0.06*
(37)
PVE 300 0.09 ± 0.03
(18)
0.06 ± 0.02***
(55)
0.06 ± 0.01**
(58)
0.05 ± 0.02***
(69)
0.04 ± 0.01***
(74)
The values represent the means difference of volume of paw ± S.E.M.; n = 5.
*p < 0.05, **p < 0.01 and ***p < 0.001, significantly different compared with control (ANOVA followed by Dunnett test).
Table 3 – Effect of intraperitoneal administration of Petit Verdot Extract (PVE) and fractions (HF, CF and EAF) on
carrageenan-induced paw edema in mice.
Group Dose (mg kg–1) Mean edema ΔV mL (percent inhibition)
1 h 2 h 3 h 4 h 5 h
Control – 0.13 ± 0.03 0.16 ± 0.03 0.17 ± 0.03 0.21 ± 0.05 0.25 ± 0.05
Indomethacin 10 0.09 ± 0.01*
(33)
0.08 ± 0.01**
(47)
0.10 ± 0.04*
(40)
0.13 ± 0.04*
(40)
0.11 ± 0.04***
(54)
PVE 300 0.09 ± 0.02*
(34)
0.09 ± 0.03**
(42)
0.11 ± 0.02*
(37)
0.14 ± 0.02**
(45)
0.12 ± 0.02**
(49)
HF 100 0.15 ± 0.03
(–)
0.09 ± 0.01
(28)
0.16 ± 0.02
(05)
0.18 ± 0.02
(13)
0.18 ± 0.03
(28)
CF 100 0.12 ± 0.03
(08)
0.10 ± 0.04
(33)
0.15 ± 0.05
(10)
0.21 ± 0.02
(–)
0.17 ± 0.02
(31)
EAF 100 0.09 ± 0.02
(33)
0.07 ± 0.03***
(55)
0.09 ± 0.03**
(48)
0.11 ± 0.03**
(48)
0.08 ± 0.03***
(67)
The values represent the means difference of volume of paw ± S.E.M.; n = 5.
*p < 0.05, **p < 0.01 and ***p < 0.001, significantly different compared with control (ANOVA followed by Dunnett test).
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gration (p < 0.05), as positive control indomethacin (p < 0.001)
used in this experiment. The EAF decreased neutrophil mi-
gration significantly at doses of 50 and 100 mg kg−1 (Fig. 1).
Subcutaneous injection of PVE at a dose of
300 mg kg−1reduced significantly (p < 0.05) levels of TNF-α and
IL1-β peritoneal washed from mice following administration
of carrageenan (Fig. 2). However, the s.c. injection of EAF at a
dose of 100 mg kg−1did not reduce significantly (p > 0.05) the
levels of TNF-α and IL1-β in the peritoneal washed from mice
following administration of carrageenan (Fig. 3).
LC-MS/MS analysis allowed the identification of 11 pheno-
lic compounds in the PVE and 12 in the EAF, by comparison
of mass spectra of authentic phenolic standards. The results
are shown in Table 5. Quantitative analysis data obtained by
HPLC-DAD are presented in Table 6.
4. Discussion
Despite the efficacy of available drugs for the treatment of in-
flammatory diseases, it is important to develop new immu-
nosuppressive drugs that avoid the side effects induced by
classical therapy, effects that lead to discontinuation of treat-
ment in a high percentage of patients (Laveti et al., 2013). In
this context, food supplements emerge as an alternative therapy
especially in chronic disease management. In recent years, the
study of the anti-inflammatory effects of bioactive molecules
present in food has become more popular between research-
ers and food manufacturers. However, efficacy and how
bioactive natural molecules influence anti-inflammatory effects
remain a question to concern (Pallarès et al., 2013).
Table 4 – Effect of Petit Verdot Extract (PVE) and ethyl acetate fraction on carrageenan-induced paw edema in mice.
Group Dose (mg kg–1) Mean edema ΔV mL (percent inhibition)
1 h 2 h 3 h 4 h 5 h
Control – 0.12 ± 0.03 0.16 ± 0.02 0.18 ± 0.02 0.19 ± 0.03 0.19 ± 0.02
Indomethacin 10 0.09 ± 0.01*
(25)
0.08 ± 0.01**
(49)
0.10 ± 0.04*
(41)
0.11 ± 0.02**
(38)
0.11 ± 0.02**
(38)
PVE 300 0.09 ± 0.02*
(34)
0.09 ± 0.03**
(42)
0.11 ± 0.02*
(37)
0.14 ± 0.02**
(45)
0.12 ± 0.02**
(49)
EAF 100 0.10 ± 0.03
(14)
0.07 ± 0.01**
(53)
0.07 ± 0.03**
(59)
0.12 ± 0.02
(36)
0.13 ± 0.03
(27)
EAF 50 0.06 ± 0.01*
(46)
0.06 ± 0.01**
(61)
0.07 ± 0.01**
(59)
0.11 ± 0.02
(38)
0.12 ± 0.02
(32)
EAF 25 0.10 ± 0.02*
(14)
0.07 ± 0.02**
(54)
0.11 ± 0.02*
(35)
0.14 ± 0.02
(26)
0.15 ± 0.01
(20)
The values represent the means difference of volume of paw ± S.E.M.; n = 5.
*p < 0.05, **p < 0.01 and ***p < 0.001, significantly different compared with control (ANOVA followed by Dunnett test).
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Fig. 1 – Neutrophil migration into the peritoneal cavity induced by carrageenan. Control (C) treated with vehicle, Petit Verdot
Extract (PVE), A and Ethyl Acetate Fraction (EAF), B followed by carrageenan injection. The results are expressed as
mean ± S.E.M., n = 5–6. The symbol (#) indicates statistical difference compared with vehicle group. The symbol (*) indicates
statistical difference compared with carrageenan group (one-way ANOVA followed by Tukey test, *p < 0.05 and **p < 0.01).
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Grape has been indicated like a promise plant food supple-
ment with anti-inflammatory properties (Dell’Agli et al., 2013)
and our results showed this possibility using grape pomace.
Considering a large amount of by-products from grape pro-
duced ever year (Melo et al., 2011; Schieber et al., 2001), such
materials seem to be an interesting source of phenolic com-
pounds (Alonso et al., 2002; Melo et al., 2011) and could be in-
corporated into pharmaceutical, nutraceutical or cosmetic
formulations (Alonso et al., 2002; Schieber et al., 2001).
To demonstrate the possible use of grape pomace as a source
of anti-inflammatory compounds, we initially investigated a
crude extract and fractions from Petit Verdot grape pomace
effects in two models of acute inflammation, neutrophil mi-
gration and paw edema, both induced by carrageenan. Carra-
geenan is a polysaccharide widely used to induce an acute
inflammatory response in experimental animals as it induces
the release of different inflammatory mediators, such as his-
tamine, bradykinin, prostaglandins, and superoxide anions.This
Control - PVE
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Carrageenan (500 μg/cavity)
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200
300
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L
Fig. 2 – Quantification of IL-1β and TNF-α in peritoneal fluid of mice. The animals were pre-treated with vehicle (saline), PVE
(300 mg kg–1) followed by carrageenan injection. The results were expressed as the mean ± standard deviation, n = 5. The
symbol (#) indicates statistical difference compared with vehicle control group. The symbol (*) indicates statistical difference
compared with carrageenan control group (ANOVA followed by Tukey test, p < 0.05).
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Fig. 3 – Quantification of IL-1β and TNF-α in peritoneal fluid of mice. The animals were pretreated with vehicle (saline), EAF
(100 mg kg–1) followed by carrageenan injection. The results were expressed as the mean ± standard deviation, n = 5. The
symbol (#) indicates statistical difference compared with vehicle control group. The symbol (*) indicates statistical difference
compared with carrageenan control group (ANOVA followed by Tukey test, p < 0.05).
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flogistic agent when injected into the peritoneal cavity or
subplantar paw area causes peritonitis or paw edema, as a result
of neutrophil migration or permeability enhancement, respec-
tively (Almeida, Bayer, Horakova, & Beaven, 1980). The admin-
istration of PVE and EAF demonstrated to be dose-dependent
and able to maintain its effects often until the last hour mea-
sured (fifth hour) in the paw edema model. The fractions HF
and CF did not inhibit paw edema indicating that the active
principles were concentrated in the polar fraction (EAF). The
preadministration of PVE and EAF also reduced neutrophil mi-
gration into the peritoneal cavity.
Even if many inflammatory markers like TNF-α, IL-1, IL-6,
IL-8 and C-reactive protein (CRP) are reported to be the major
key factors with proved role in several inflammatory dis-
eases, IL-1 and TNF-α are the important cytokines that can
induce the expression of NF-kB, which is the potential target
in inflammatory diseases (Laveti et al., 2013). The release of
inflammatory cytokines, consequently induce rolling and ad-
hesion of neutrophils in the vascular endothelium, and trans-
migration into the inflammatory site (Franchin et al., 2012).
As polyphenols commonly found in grape products have been
reported to reduce inflammation by different mechanisms in-
cluding blocking pro-inflammatory cytokines (Chuang &
McIntosh, 2011), we also quantified IL-1β and TNF-α into the
peritoneal fluid after PVE and EAF administration.
The first cytokine measured, the tumor necrosis factor (TNF-
α) is related with acute and chronic inflammatory responses.
It is produced by various types of cells, especially monocytes/
macrophages, which infiltrate inflammatory sites, and is im-
plicated in the pathogenesis of a variety of chronic
inflammatory diseases, such as type 2 diabetes, rheumatoid
arthritis, and inflammatory bowel disease (Kawaguchi,
Matsumot, & Kumazawa, 2011). The interleukin-1 beta (IL-1β)
is also a potent pro-inflammatory cytokine, and is involved
in a variety of cellular activities, including cell proliferation,
differentiation, and apoptosis. In addition to its patho-
physiologic role in host protection, IL-1β promotes the pro-
gression of a number of autoimmune diseases (Zhao, Zhou,
& Su, 2013).
The treatment with PVE reduces levels of TNF-α and IL1-β
into the peritoneal fluid; however, EAF was not able to inhibit
those inflammatory cytokines. One possibility could be a low
dose administrated, once we observed a reduction, but not quite
significantly.The success of the PVE on cytokine inhibition may
suggest a synergistic effect, once the extract it is a blend of
Table 5 – Ion transitions monitored by MS/MS under
MRM mode for PVE and EAF.
Compounds Molecular ion
[M–H]− or
[M + H]+ (m/z)
MS/MS ions
1 Gallic acid 169 125
2 Syringic acid 197 169, 125
3 Procyanidin B1 577 425, 407, 289
4 Procyanidin B2 577 425, 407, 289
5 Catechin 289 245, 205, 179
6 Epicatechin 289 245, 205, 179
7 Epicatechin-3-O-gallate 441 289, 169
8 Trans-resveratrola 227 159, 185
9 Trans-piceid 389 227
10 Peonidin-3-O-glucoside 463 301
11 Malvidin-3-O-glucoside 493 331
12 Delphinidin-3-O-glucoside 465 303
a Not identified in PVE.
Table 6 – Quantification of phenolic compounds in PVE and EAF by HPLC.
Compounds LOD (μg) LOQ (μg) Samples Quantity (μg/mg)
Hydroxybenzoic acids Gallic acid 0.005 0.01 PVE 1.36
EAF 8.01
Syringic acid 0.0007 0.002 PVE 0.15
EAF 0.99
Proanthocyanidins Procyanidin B1 0.004 0.014 PVE 0.81
EAF 7.81
Procyanidin B2 0.006 0.02 PVE 1.61
EAF 19.53
Flavan-3-ol monomers Catechin 0.03 0.09 PVE 3.99
EAF 31.78
Epicatechin 0.01 0.032 PVE 5.03
EAF 39.10
Epicatechin-3-O-gallate 0.003 0.016 PVE 0.19
EAF 9.58
Anthocyanins Peonidin-3-O-glucoside 0.0012 0.0035 PVE 0.59
EAF 0.08
Malvidin-3-O-glucoside 0.0075 0.023 PVE 8.35
EAF 1.74
Delphinidin-3-O-glucoside 0.0012 0.0035 PVE 1.18
EAF 0.03
Total phenolicsa 0.04 0.11 PVE 228.20
EAF 529.45
LOD, limits of detection; LOQ, limits of quantification.
a Total phenolics by Folin–Ciocalteu method expressed as Gallic Acid Equivalent.
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anti-inflammatory active compounds. Consistent with our data
about the extract, other reports showed that grape extracts in-
hibitedTNF-α (Pallarès et al., 2013; Terra et al., 2009), IL-1β (Chae
et al., 2007; Gessner et al., 2012; Ludwig et al., 2004) and other
pro-inflammatory cytokines, such as IL-6 (Terra et al., 2009) and
IL-8 (Gessner et al., 2012), among others.
Concerning the active compounds identified in grape, several
authors have reported the presence of numerous polyphe-
nols, resveratrol, quercetin, catechins and anthocyanins among
others (Dell’Agli et al., 2013; Moure et al., 2001; Yadav et al.,
2009). In the pomace, the most abundant compounds identi-
fied are gallic acid, catechin and epicatechin (Alonso et al.,
2002). All these compounds have shown a potential antioxi-
dant (Melo et al., 2011; Moure et al., 2001) and anti-inflammatory
properties (Dell’Agli et al., 2013; Huo et al., 2008). This study
identified in the PVE the following phenolic compounds by
LC-MS/MS technique: gallic acid and syringic acid; procyanidins
B1 and B2; catechin, epicatechin and epicatechin-3-O-gallate;
trans-piceid and peonidin-3-O-glucoside, malvidin-3-O-
glucoside and delphinidin-3-O-glucoside. In addition to those
identified compounds in PVE, the EAF sample showed the
presence of the stilbene trans-resveratrol. The high concen-
tration of catechin (31.78 μg/mg), epicatechin (39.10 μg/mg),
epicatechin 3-gallate (9.58 μg/mg), procyanidins B1 (7.81 μg/
mg), procyanidins B2 (19.53 μg/mg) and gallic acid (8.01 μg/
mg) quantified by HPLC-DAD in the EAF could indicate a
prospective fraction rich in phenolic compounds with signifi-
cant functional properties.
Thus, this research aimed to stimulate the development of
new sources of phenolic compounds with anti-inflammatory
activity. An investment in studies on agro-industrial by-
products may lead to satisfactory results designed for appli-
cation to pharmaceuticals and food products, in addition to
helping with pollution problems related to its disposal.
5. Conclusion
Taken together, the PVE and EAF affect neutrophil migration
and paw edema induced by carrageenan, besides the extract
was also able to inhibit pro-inflammatory cytokines.Thus, the
presence of hydroxybenzoic acids, proanthocyanidins, flavan-
3-ol monomers and anthocyanins present in the PVE and EAF
added to the effect observed, may have contributed not only
to improve the hypothesis that phenolic compounds in grapes
have obviously anti-inflammatory properties, but also that
the pomace could be a remarkable source of functional
compounds.
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